KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Acquisitions (2021 - 2022)

Historic Acquisitions for Bionano Genomics (BNGO) over the last 2 years, with Q4 2022 value amounting to $32.0 million.

  • Bionano Genomics' Acquisitions fell 3473.09% to $32.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $31.3 million, marking a year-over-year decrease of 3614.47%. This contributed to the annual value of $31.3 million for FY2022, which is 3614.47% down from last year.
  • Per Bionano Genomics' latest filing, its Acquisitions stood at $32.0 million for Q4 2022, which was down 3473.09% from -$694000.0 recorded in Q1 2022.
  • Over the past 5 years, Bionano Genomics' Acquisitions peaked at $49.1 million during Q4 2021, and registered a low of -$694000.0 during Q1 2022.